Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0005313704
Mon, 29.01.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jena, 29 January 2024
The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f [ … ]
Fri, 15.12.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
Jena, December 15, 2023
Carl Zeiss Meditec AG (ISIN: DE0005313704) announces today that it has entered into a definitive agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), from the investment firm [ … ]
Wed, 19.04.2023
Carl Zeiss Meditec AG
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Jena, April 19, 2023
In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati [ … ]
Wed, 19.04.2023
Carl Zeiss Meditec AG
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Jena, April 19, 2023
In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati [ … ]
Thu, 30.09.2021
Carl Zeiss Meditec AG
Leadership Change in the Executive Board of Carl Zeiss Meditec AG
Jena, September 30, 2021
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has agreed on a change in the Executive Board of the company. Dr. Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will turn over his position to Dr. Mark [ … ]
Fri, 16.07.2021
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 1,198.2 million after nine months of fiscal year 2020/21 (past year: EUR 967.9 million). This corresponds to a revenue development of +23.8% vs. the past year (after adjustment for currency effects[1]: +27.6%). In the third quarter of FY 2020/21, revenue amounted to EUR [ … ]
Mon, 19.04.2021
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG returns to significant revenue growth in second quarter 2020/21
Jena, April 19, 2021
Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 767.4 million in the first half of fiscal year 2020/21 (previous year: EUR 714.9 million). This corresponds to a revenue development of +7.3% vs. the past year (af [ … ]
Tue, 19.01.2021
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21
Jena, January 19, 2021
Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 368.9 million in the first quarter of fiscal year 2020/21 (previous year: EUR 369.7 million). This corresponds to a revenue development of -0.2% vs. the past year (after adjust [ … ]
Thu, 29.10.2020
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG concludes fiscal year 2019/20 with a recovery in profit in fourth quarter - outlook remains uncertain due to COVID-19 pandemic
Jena, October 29, 2020
Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of approximately EUR 1,335.5 million in fiscal year 2019/20 (previous year EUR 1,459.3 million) and has there [ … ]